Dilated Cardiomyopathy

Gene: ACTN2

Green List (high evidence)

ACTN2 (actinin alpha 2)
EnsemblGeneIds (GRCh38): ENSG00000077522
EnsemblGeneIds (GRCh37): ENSG00000077522
OMIM: 102573, Gene2Phenotype
ACTN2 is in 8 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

The ClinGen cardiomyopathy moderate curation was done back in 2018, there have been many new publications since. There is enough evidence suggesting loss of function is a mechanism of disease (along with dominant negative)
gnomAD v2.1: LOEUF=0.24
Cardiac evidence
LoF
At least 11 truncating (1 in last exon), one of which is de novo, loss of function zebrafish model, patient hiPCS cardiomyocytes with a cardiac phenotype
2 - PMID: 34802252 - ACTN2, p.Gln860Ter (last exon) identified homozygous in a individual with cardiomyopathy and atrial fibrillation, had a translplant in her 20s & proband with frameshift ACTN2 exon 8-10 deletion and cardiomyopathy, ventricular tachycardia, and atrial fibrillation. The deletion segregated in 6 affected family members. Studied human iPSC-derived cardiomyocytes from both probands. Patient-derived iPSC-cardiomyocytes were hypertrophic, displayed sarcomeric structural disarray, impaired contractility, and aberrant Ca2+-signaling. In heterozygous indel cells, the truncated protein incorporates into cardiac sarcomeres, leading to aberrant Z-disc ultrastructure. In homozygous stop-gain cells, affinity-purification mass-spectrometry reveals an intricate ACTN2 interactome with sarcomere and sarcolemma-associated proteins
4 - PMID: 33500567 - significant association between ACTN2 truncating variants and LVNC in a meta-analysis compared to gnomAD. gnomAD count: 13/125,085, gnomAD freq 0.01%, LVNC count: 4/611, LVNC freq: 0.66%, Case excess: 0.65%, p value=1.3E-06, OR 63.4 (20.6–195.0)
variants from this study include PMID: 29447731 - NM_001103.2 p.(Trp303*) in 1 proband and NM_001103.2 p.(Asp196Thrfs*14) in another proband with non-compaction cardiomyopathy. Also 1 proband NCCM with NM_001103.2:c.574C>T p.(Arg192*) and a frameshift SCN5A variant (also reported in PMID: 32445794). Study also includes PMID: 30471092 and PMID: 28798025
1 - PMID: 32973354 - 1 individual with LVNC and 2 affected individuals with HCM with a frameshift ACTN2 exon 3-6 deletion
1 de novo - PMID: 31333075 - Infant with LVNC and requiring transplant with NM_001103.2:c.574C>T p.(Arg192*) de novo, MYLK2 variant inherited from father with trabeculation, & EYA4 variant inherited from unaffected mother. (also reported in PMID: 34540771, 31568572)
1 - PMID: 28436997 - NM_001103.2:c.574C>T p.(Arg192*) identified in a DCM patient
PMID: 22767232 - loss-of-function studies by antisense morpholino technology in zebrafish. Depletion of actn2 did not affect the early steps of sarcomere assembly but reduced cardiac function, primarily characterized as a reduced end-diastolic diameter. The depletion of actn2 also significantly reduced the ventricle chamber size, due to both reduced cardiomyocyte (CM) size and CM number.
1 - SCV001192606.1 - NM_001103.4(ACTN2):c.229G>T (p.Glu77Ter) - at least one individual with DCM submitted by Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare
1 - SCV002058317.1 - NM_001103.4(ACTN2):c.311T>A (p.Leu104Ter) - single heterozygote with Coronary artery atherosclerosis (present) , Left ventricular diastolic dysfunction (present) , Left ventricular hypertrophy (present) , Orthostatic hypotension (present) submitted by 3billion
Missense:
PMID: 36078153 - ACTN2mut c.740C>T p.Thr247Met hiPSC-CMs present hypertrophy, myofibrillar disarray, ACTN2 aggregation, a higher percentage of multinucleation, and activation of both UPS and ALP. It was associated with a marked reduction of sarcomere-associated protein levels and force impairment
PMID: 31956495 - c.1418A>G (p.Tyr473Cys) segregates with left-dominant arrhythmogenic cardiomyopathy in 4 individuals in a single Swiss family. Variant is present in 4 hets in gnomAD v3.1 and absent from v2.1.
PMID: 27287556 - assessed the function of A119T and G111V in in vitro assays. Determined the variants have small effects on structure, function and behaviour (F-actin binding affinity and altered Z-disc localization and dynamics), which may contribute to a mild phenotype for this disease
PMID: 25224718 - a second Australian family with p.(Ala119Thr) segregating diverse cardiac phenotypes including idiopathic ventricular fibrillation, LVNC, and sudden unexplained death. 4 affected individuals and 1 clinically unaffected individual with the variant.
PMID: 25173926 - missense NM_001103.2:c.683T>C p.(Met228Thr) identified in a 4 generation Italian family. 11 individuals with LVH/Arrhythmias/noncompaction with the variant, and additional 3 affected obligate carriers. 4 individuals with noncompaction cardiomyopathy.
PMID: 20022194 - an Australian HCM family with variable phenotypes including syncope, heart failure, and premature sudden death. ACTN2 missense NM_001103.4:c.355G>A p.(Ala119Thr) (absent from gnomAD v2.1 & v3.1) identified in 7 affected individuals and 2 asymptomatic individuals. Variant not present in 5 relatives that screened normal. T495M identified in 2 unrelated HCM probands, and in 1 family member with abnormal echo (but see gnomAD frequency data below). Glu628Gly (absent from gnomAD) identified in a HCM proband, segregated to 1 offspring with abnormal ECG and 1 offspring with normal screening. Glu583Ala (6 alleles in gnomAD v2.1) identified in a HCM proband.
PMID: 17097056 - 3 HCM probands from Mayo clinic with 3 different missense variants, 1 is more common than you would expect for HCM: G111V (absent gnomAD v2.1 & v3.1), T495M (gnomAD v2.1 78 alleles, 1 hom, Euro (NF) AF 0.0004492; gnomAD v3.1 (non-v2) 30 alleles), R759T (absent gnomAD v2.1 & v3.1)
Created: 12 Jul 2023, 6:05 a.m. | Last Modified: 12 Jul 2023, 6:05 a.m.
Panel Version: 1.16

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Cardiomyopathy, dilated, 1AA, with or without LVNC, MIM# 612158

Paul De Fazio (Victorian Clinical Genetics Services)

I don't know

Moderate evidence for "intrinsic cardiomyopathy" according to ClinGen. Associated with both HCM and DCM (same MIM# for both).

According to ClinGen; 12 unique heterozygous variants have been identified in the context of diverse cardiac phenotypes (HCM, DCM, LVNC, ventricular fibrillation).

In DCM:
PMID 20474083: 3 "variants of likely clinical significance" and 1 VUS, cohort study
PMID 14567970: missense variant in a child who died of DCM
PMID 25224718: 2 families with the same missense variant (same haplotype)

Rescues a DCM phenotype in Zebrafish (PMID: 22253474).

Green on PanelApp GEL but did not achieve consensus Green rating. Amber on PanelApp Aus HCM panel.
Sources: Literature
Created: 3 Aug 2020, 12:12 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Intrinsic cardiomyopathy

Publications

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Green
Phenotypes
  • Cardiomyopathy, dilated, 1AA, with or without LVNC, MIM# 612158
OMIM
102573
Clinvar variants
Variants in ACTN2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

12 Jul 2023, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: ACTN2 were changed from Intrinsic cardiomyopathy to Cardiomyopathy, dilated, 1AA, with or without LVNC, MIM# 612158

12 Jul 2023, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: actn2 has been classified as Green List (High Evidence).

3 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: actn2 has been classified as Amber List (Moderate Evidence).

3 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: actn2 has been classified as Amber List (Moderate Evidence).

3 Aug 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Paul De Fazio (Victorian Clinical Genetics Services)

gene: ACTN2 was added gene: ACTN2 was added to Dilated Cardiomyopathy. Sources: Literature Mode of inheritance for gene: ACTN2 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: ACTN2 were set to 20474083; 25224718; 22253474; 14567970: Phenotypes for gene: ACTN2 were set to Intrinsic cardiomyopathy Review for gene: ACTN2 was set to AMBER gene: ACTN2 was marked as current diagnostic